Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages

• Published in: PloS one 2024-04, Vol.19 (4), p.e0301904-e0301904
• Main Authors: Karpurapu, Manjula, Kakarala, Kavita Kumari, Chung, Sangwoon, Nie, Yunjuan, Koley, Amritendu, Dougherty, Patrick, Christman, John W
• Format: Article
• Language: English
• Subjects: Animals; Biology and life sciences; Catechin; Catechin - analogs & derivatives; Catechin - pharmacology; DNA - metabolism; DNA-ligand interactions; Gene Expression Regulation - drug effects; Genes; Genetic aspects; Green tea; Health aspects; Hydrogen; Lipopolysaccharides - pharmacology; Lung diseases; Lysine; Macrophages; Macrophages - drug effects; Macrophages - metabolism; Medicine and Health Sciences; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Physical Sciences; Physiological aspects; Protein Binding; Proto-Oncogene Proteins - genetics; Proto-Oncogene Proteins - metabolism; Research and analysis methods; Trans-Activators - genetics; Trans-Activators - metabolism; Transcription factors; Tryptophan; Type 2 diabetes
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0301904

Our previous research demonstrated that PU.1 regulates expression of the genes involved in inflammation in macrophages. Selective knockdown of PU.1 in macrophages ameliorated LPS-induced acute lung injury (ALI) in bone marrow chimera mice. Inhibitors that block the transcriptional activity of PU.1 in macrophages have the potential to mitigate the pathophysiology of LPS-induced ALI. However, complete inactivation of PU.1 gene disrupts normal myelopoiesis. Although the green tea polyphenol Epigallocatechin gallate (EGCG) has been shown to regulate inflammatory genes in various cell types, it is not known if EGCG alters the transcriptional activity of PU.1 protein. Using Schrodinger Glide docking, we have identified that EGCG binds with PU.1 protein, altering its DNA-binding and self-dimerization activity. In silico analysis shows that EGCG forms Hydrogen bonds with Glutamic Acid 209, Leucine 250 in DNA binding and Lysine 196, Tryptophan 193, and Leucine 182 in the self-dimerization domain of the PU.1 protein. Experimental validation using mouse bone marrow-derived macrophages (BMDM) confirmed that EGCG inhibits both DNA binding by PU.1 and self-dimerization. Importantly, EGCG had no impact on expression of the total PU.1 protein levels but significantly reduced expression of various inflammatory genes and generation of ROS. In summary, we report that EGCG acts as an inhibitor of the PU.1 transcription factor in macrophages.